Cargando…
Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
The underlying molecular heterogeneity of cancer is responsible for the dynamic clinical landscape of this disease. The combination of genomic and proteomic alterations, including both inherited and acquired mutations, promotes tumor diversity and accounts for variable disease progression, therapeut...
Autores principales: | Khella, Christen A., Mehta, Gaurav A., Mehta, Rushabh N., Gatza, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922242/ https://www.ncbi.nlm.nih.gov/pubmed/33669749 http://dx.doi.org/10.3390/jpm11020149 |
Ejemplares similares
-
Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis
por: Karagoz, Kubra, et al.
Publicado: (2019) -
SOX4-SMARCA4 complex promotes glycolysis-dependent TNBC cell growth through transcriptional regulation of Hexokinase 2
por: Khanna, Pooja, et al.
Publicado: (2023) -
SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2
por: Mehta, Gaurav A., et al.
Publicado: (2021) -
Missing data in multi-omics integration: Recent advances through artificial intelligence
por: Flores, Javier E., et al.
Publicado: (2023) -
Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)